Afya (AFYA) to Release Earnings on Thursday

Key Points

• Afya (NASDAQ:AFYA) is set to release its Q2 2025 earnings on August 21st, with analysts predicting earnings of $0.40 per share and revenue of $924.32 million.
• In its previous earnings report, Afya beat expectations, reporting an EPS of $0.39, above the consensus estimate of $0.38.
• The company's stock currently has an average rating of "Hold" from analysts, with a target price around $17.50.

Afya (NASDAQ:AFYA - Get Free Report) is expected to be releasing its Q2 2025 earnings data before the market opens on Thursday, August 21st. Analysts expect Afya to post earnings of $0.40 per share and revenue of $924.32 million for the quarter. Afya has set its FY 2025 guidance at EPS.

Afya (NASDAQ:AFYA - Get Free Report) last issued its earnings results on Wednesday, August 13th. The company reported $0.39 EPS for the quarter, beating the consensus estimate of $0.38 by $0.01. Afya had a net margin of 19.83% and a return on equity of 19.13%. On average, analysts expect Afya to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Afya Price Performance

Shares of NASDAQ:AFYA opened at $14.92 on Thursday. The firm has a 50 day moving average of $16.21 and a 200-day moving average of $17.24. The stock has a market capitalization of $1.40 billion, a PE ratio of 11.30, a PEG ratio of 0.52 and a beta of 0.53. The company has a current ratio of 1.42, a quick ratio of 1.42 and a debt-to-equity ratio of 0.41. Afya has a 12 month low of $13.47 and a 12 month high of $19.90.

Institutional Trading of Afya

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Jump Financial LLC purchased a new stake in shares of Afya during the 2nd quarter valued at about $731,000. Marshall Wace LLP purchased a new stake in shares of Afya during the 2nd quarter valued at about $249,000. Arrowstreet Capital Limited Partnership boosted its holdings in shares of Afya by 5.6% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 68,169 shares of the company's stock valued at $1,217,000 after acquiring an additional 3,626 shares during the last quarter. Quantbot Technologies LP purchased a new stake in shares of Afya during the 2nd quarter valued at about $117,000. Finally, Geode Capital Management LLC increased its position in shares of Afya by 85.1% during the 2nd quarter. Geode Capital Management LLC now owns 52,111 shares of the company's stock valued at $931,000 after purchasing an additional 23,961 shares during the last quarter. 88.02% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on AFYA shares. Citigroup raised Afya from a "sell" rating to a "neutral" rating and lowered their price objective for the company from $16.00 to $14.00 in a research note on Tuesday, July 29th. UBS Group reaffirmed a "neutral" rating and set a $19.50 target price (up previously from $17.50) on shares of Afya in a research note on Thursday, June 12th. Morgan Stanley set a $17.50 price target on Afya and gave the stock an "overweight" rating in a report on Wednesday, August 6th. Finally, Wall Street Zen lowered Afya from a "buy" rating to a "hold" rating in a report on Saturday, July 26th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and one has assigned a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Hold" and an average target price of $17.50.

Afya Company Profile

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.